Sudden cardiac death in young athletes: exome sequencing results
Genes & Cells · 2024
DOI: 10.17816/gc569201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Cells, 2024. Verfasst von Roman V. Deev und 6 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Ranking risks and prevention of sudden cardiac death in professional young athletes is a crucial unresolved problem in sports medicine. Intense physical exertion can lead to adaptive changes in the cardiovascular system, which can mask inherited diseases with predominant myocardial involvement, such as hypertrophic cardiomyopathy. Undiagnosed cases of such diseases can be a risk factor for fatal outcomes associated with training and competitive activities, making this problem extremely relevant. AIM: To conduct a diagnostic search for possible molecular causes of cardiovascular diseases associated with a high risk of sudden death in young athletes. MATERIALS AND METHODS: Whole-exome sequencing of DNA extracted from two groups of biomaterials was performed: nine autopsy samples of heart tissues from young athletes who died during intense physical exertion and three venous blood samples from active athletes of the Russian national team. Obtained data were subjected to bioinformatic analysis and clinical interpretation. RESULTS: In total, 12 DNA samples were analyzed using a panel of 277 genes associated with the development of cardiovascular diseases with a high risk of sudden death. In 4 of 12 samples (33.3%), variants possibly related to the phenotype were found upon clinical interpretation of the sequencing results. A pathogenic variant was found in the MYBPC3 gene, leading to the development of hypertrophic cardiomyopathy (OMIM: 115197), and a potential pathogenic variant was found in the TRPM4 gene, associated with progressive familial heart block type IB (OMIM: 618531). Moreover, two variants with uncertain clinical significance were found in CAV3 and SCN1B. CONCLUSION: Currently, data from high-throughput sequencing are collected to identify the molecular basis of cardiovascular diseases with a high risk of sudden cardiac death. Identifying young athletes who are carriers of pathogenic and possibly pathogenic gene variants is beneficial for preventing fatal outcomes and personalizing medical support for professional athletes.
Zitieren
APA
Deev, R. V., Kadykova, A. I., Shilova, M. A., Sharova, E. I., Fedyushkina, I. V., Kulemin, N. A., & Zholinsky, A. V. (2024). Sudden cardiac death in young athletes: exome sequencing results. Genes & Cells. https://doi.org/10.17816/gc569201
Vancouver
Deev RV, Kadykova AI, Shilova MA, Sharova EI, Fedyushkina IV, Kulemin NA, et al. Sudden cardiac death in young athletes: exome sequencing results. Genes & Cells. 2024. doi:10.17816/gc569201
BibTeX
@article{Deev2024,
author = {Deev, Roman V. and Kadykova, Anastasia I. and Shilova, Marina A. and Sharova, Elena I. and Fedyushkina, Irina V. and Kulemin, Nikolay A. and Zholinsky, Andrey V.},
title = {Sudden cardiac death in young athletes: exome sequencing results},
journal = {Genes & Cells},
year = {2024},
doi = {10.17816/gc569201}
}
EUVIMED